Grannus Therapeutics

United States
Indianapolis, Indiana, United States, 46240

Company profile

Grannus Therapeutics company profile

Grannus Therapeutics is a biotechnology company that focuses on the development of small-molecule inhibitors for specific isoforms of HSP90. The company was founded in 2020 and is headquartered in Indianapolis, Indiana.

Business identity

Phone number
317-414-6205
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2020-01-01, Year

Headquarters

Postal code
46240
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
3
Total equity funding
$950,000
Last funding
Debt Financing / $800,000 / 2024-01-11
Last equity funding
Pre Seed / $950,000
Investors
1
Lead investors
1
Founders
2
Articles
4

Founders and investors

Founders

John FoglesongSanket Mishra

Lead investors

Elevate Ventures

Investors

Elevate Ventures